Page 820 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 820

806 C H A P T E R 21 Peripheral Nerves and Muscles

 AB C

Figure 21–6  Inflammatory myopathies. A, Polymyositis is characterized by endomysial inflammatory infiltrates and myofiber necrosis (arrow).
B, Dermatomyositis often shows prominent perifascicular and paraseptal atrophy. C, Inclusion body myositis, showing myofibers containing rimmed
vacuoles (arrows). Modified Gomori trichrome stain.

•	 Thyrotoxic myopathy may take the form of either acute or         PERIPHERAL NERVE SHEATH TUMORS
   chronic proximal muscle weakness, and can be the first
   indication of thyrotoxicosis. Histologic findings include       A number of different tumors arise from peripheral nerves.
   myofiber necrosis and regeneration.                             Such tumors may manifest as soft tissue masses or with
                                                                   pain or loss of function related to impingement on nerves
•	 Ethanol myopathy occurs after an episode of binge drink-        or other surrounding structures. In most peripheral nerve
   ing. The degree of rhabdomyolysis may be severe, some-          tumors, the neoplastic cells show evidence of Schwann cell
   times leading to acute renal failure secondary to               differentiation. These tumors usually occur in adults and
   myoglobinuria. Patients usually complain of acute               include both benign and malignant variants. An important
   muscle pain, which may be generalized or confined to a          feature is their frequent association with the familial tumor
   single muscle group. Microscopically, there is myocyte          syndromes neurofibromatosis type 1 (NF1) and neurofibro-
   swelling, necrosis, and regeneration.                           matosis type 2 (NF2). Tumors with skeletal muscle differ-
                                                                   entiation also occur; these are discussed in Chapter 20,
•	 Drug myopathy can be produced by a variety of agents.           along with other tumors of soft tissues.
   Currently the most commonly implicated drugs are
   those belonging to the statin family. The affected muscles      Schwannomas and Neurofibromatosis Type 2
   show evidence of myopathic injury, usually without an
   inflammatory component.                                         Schwannomas are benign encapsulated tumors that may
                                                                   occur in soft tissues, internal organs, or spinal nerve roots.
    S U M M A RY                                                   The most commonly affected cranial nerve is the vestibular
 Disorders of Skeletal Muscle                                      portion of the eighth nerve. Tumors arising in a nerve root
                                                                   or the vestibular nerve may be associated with symptoms
 •	 Skeletal muscle function can be impaired secondarily           related to nerve root compression, which includes hearing
      because of problems with muscle innervation or by a          loss in the case of vestibular schwannomas.
      primary myopathy that can be inherited or acquired.
                                                                      Most schwannomas are sporadic, but about 10% are
 •	 The genetic forms of myopathy fall into several fairly         associated with familial neurofibromatosis type 2. NF2
      distinct clinical phenotypes, including muscular dystrophy,  patients are at risk of developing multiple schwannomas,
      congenital myopathy, and congenital muscular dystrophy.      meningiomas, and ependymomas (the latter are described
                                                                   in Chapter 22). The presence of bilateral vestibular
 •	 Dystrophinopathies are X-linked disorders caused by            schwannomas is a hallmark of NF2. Affected patients carry
      mutations in the dystrophin gene and disruption of the       a dominant loss of function mutation of the merlin gene on
      dystrophin-glycoprotein complex. Depending on the type       chromosome 22. Merlin is a cytoskeletal protein that func-
      of mutation the disease may be severe, such as Duchenne      tions as a tumor suppressor by facilitating E-cadherin–
      muscular dystrophy, or mild (e.g., Becker dystrophy).        mediated contact inhibition (Chapter 5). Of note, merlin
                                                                   expression is also disrupted in sporadic schwannomas.
 •	 Acquired myopathies have diverse causes, including inflam-     Despite the name of the syndrome, neurofibromas are not
      mation and toxic exposures.                                  a feature of NF2. Schwannomatosis is a familial condition
   815   816   817   818   819   820   821   822   823   824   825